ABN-912

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameABN-912
Drug Alias NameABN912Anti-MCP-1 monoclonal antibodyABN-912
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-C motif chemokine 2 inhibitors
TargetsC-C motif chemokine 2
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A